title: Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains.
abstract: Immunohistochemisty with RD3, a monoclonal antibody specific for three-repeat (3R) tau, is sometimes hampered by diffuse neuronal staining on formalin-fixed, paraffin-embedded sections pretreated with formic acid and heating. Additional pretreatment with potassium permanganate followed by oxalic acid completely eliminated this diffuse RD3-immunoreactivity (IR) in neurons. Furthermore, this additional pretreatment uniformly enhanced RD3-IR, as well as RD4-IR, a monoclonal antibody specific for four-repeat (4R) tau, on pathological deposits with tau IR. This enhanced sensitivity and specificity may allow more reliable identification of 3R and 4R tau in pathological deposits, which may be variable dependent on disease and regions. Cerebral cortex and midbrain from 8 patients [5 progressive supranuclear palsy (PSP) and 3 corticobasal degeneration (CBD)] were screened for RD3- and RD4-IR with this improved procedure. In addition to RD4-positive structures found both in cerebral cortex and brainstem, RD3-positive neurofibrillary tangles (NFTs) were also found in midbrain in 7 of these 8 cases but not in the cortex. Multi-labeling study demonstrated that most of RD3-negative neurons were positive for RD4. This reliable demonstration of pathological 3R tau deposits in the brainstem of PSP/CBD, so far presumably characterized by deposition of 4R tau, is useful to map tau-positive lesions according to their biochemical composition.
authors.affiliation: Department of Neurology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan. uchihara-ts@igakuken.or.jp
authors.forename: Toshiki
authors.initials: T
authors.lastname: Uchihara
authors.forename: Ayako
authors.initials: A
authors.lastname: Nakamura
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Shibuya
authors.forename: Saburo
authors.initials: S
authors.lastname: Yagishita
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal; D001921:Brain / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D007202:Indicators and Reagents; D008297:Male; D008875:Middle Aged; D016874:Neurofibrillary Tangles / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D019815:Oxalic Acid; D011196:Potassium Permanganate; D012680:Sensitivity and Specificity; D013494:Supranuclear Palsy, Progressive / Q000378:metabolism / Q000473:pathology*; D016875:tau Proteins / Q000032:analysis*
chemical_list: D000911:Antibodies, Monoclonal; D007202:Indicators and Reagents; D016875:tau Proteins; D011196:Potassium Permanganate; D019815:Oxalic Acid
references.citation: J Neuropathol Exp Neurol. 2010 Jan;69(1):40-52
references.pmid: 20010304
references.citation: Acta Neuropathol. 2007 May;113(5):483-99
references.pmid: 17401570
references.citation: Brain. 2005 Jun;128(Pt 6):1247-58
references.pmid: 15788542
references.citation: Neurology. 1994 Nov;44(11):2015-9
references.pmid: 7969952
references.citation: J Histochem Cytochem. 1957 Jul;5(4):346-53
references.pmid: 13463308
references.citation: J Neuropathol Exp Neurol. 2009 Sep;68(9):1029-36
references.pmid: 19680140
references.citation: Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):95-101
references.pmid: 14969740
references.citation: Acta Neuropathol. 2006 Oct;112(4):389-404
references.pmid: 16906426
references.citation: FEBS Lett. 2002 Nov 20;531(3):538-42
references.pmid: 12435607
references.citation: J Neuropathol Exp Neurol. 2002 Dec;61(12):1040-7
references.pmid: 12484566
references.citation: Acta Neuropathol. 1992;84(3):265-72
references.pmid: 1384266
references.citation: Neuropathol Appl Neurobiol. 2009 Dec;35(6):532-54
references.pmid: 19682326
references.citation: J Neuropathol Exp Neurol. 1996 Jan;55(1):97-105
references.pmid: 8558176
references.citation: Acta Neuropathol. 1994;88(4):379-83
references.pmid: 7839832
references.citation: Neuropathology. 2006 Oct;26(5):457-70
references.pmid: 17080726
references.citation: Acta Neuropathol. 2004 Feb;107(2):181-2
references.pmid: 14652684
references.citation: J Neurol. 1995 Aug;242(8):485-9
references.pmid: 8530974
references.citation: Acta Neuropathol. 2006 Apr;111(4):329-40
references.pmid: 16552612
references.citation: Neuropathol Appl Neurobiol. 2003 Jun;29(3):288-302
references.pmid: 12787326